SAKK 01/18 Reduced intensity radio-chemotherapy for satge IIA/B seminoma. A multicenter, open label phase II trial with 2 cohorts
Ongoing - recruitment active · 2019 until 2030
Putora Paul Martin, Plasswilm Ludwig, Panje Cédric, Omlin Aurelius, Rothermundt Christian, Aeppli Stefanie
Main objective: To investigate efficacy of a stage-adapted tratment regimen in stage IIA/B seminoma based on the preliminary experience gained in SAKK 01/10. The Goal is to further safely de-escalate Treatment while maintaining / enhancing efficacy.